Massachusetts Institute of Technology

Hospital Universitario La Fe University of Valencia

U.S. Food and Drug Administration (FDA)

Uchealth Transplant Center

This scientific session focuses on novel experimental approaches and molecular insights into the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD), exploring potential therapeutic targets for its treatment.

The diagnosis and management of childhood liver disorders are undergoing rapid changes, aided by novel investigative approaches. In this session, attendees will learn from state-of-the-art clinical and translational studies advancing the field of pediatri